Table 1.
Various Ongoing clinical trials for evaluation of Chloroquine (https://clinicaltrials.gov/ct2/results).
| Clinical Trial Number | Description | Phase | Dose | Location |
|---|---|---|---|---|
| NCT04328493 | Treatment with Chloroquine in patients in Vietnam | 2 | the loading dose of 1200 mg, 300 mg base orally once daily for 9 days | Vietnam |
| NCT04344951 | An Open-Label, Non-Randomized Clinical Trial utilizing Chloroquine Phosphate Against COVID-19 | 2 | 500 mg two times a day for seven days. | Greece |
| NCT04333628 | The utilization of Chloroquine for Mild Symptomatic and Asymptomatic COVID-19 | 2,3 | Low dose- 125 mg every day for 7 days High dose- 500 mg two times a day for 7 days |
Israel |
| NCT04349371 | Determination of the clinical efficacy of Chloroquine in health care workers | 2 | 250 mg once daily for 1 week then 2 tabs of 250 mg for once for 7 days for 3 months | United States |
| NCT04351724 | Aimed at the evaluation of the efficacy of various anti-viral treatments | 2,3 | 250 mg | Austria |